$OCLS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sonoma Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sonoma Pharmaceuticals, Inc.. Get notifications about new insider transactions in Sonoma Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2021 | OCLS | Sonoma Pharmaceuti ... | DVONCH JEROME J | Chief Financial Off ... | Option Exercise | A | 8.03 | 27,777 | 223,049 | 27,777 | |
| Jan 08 2021 | OCLS | Sonoma Pharmaceuti ... | Trombly Amy Moss | Chief Executive Off ... | Option Exercise | A | 8.03 | 27,777 | 223,049 | 43,648 | |
| Apr 24 2020 | OCLS | Sonoma Pharmaceuti ... | Edwards Robert Grant | Chief Financial Off ... | Grant | A | 0.00 | 2,609 | 0 | 2,609 | 0 to 2.6 K |
| Apr 24 2020 | OCLS | Sonoma Pharmaceuti ... | Dal Poggetto John | Chief Financial Off ... | Grant | A | 0.00 | 3,086 | 0 | 3,201 | 115 to 3.2 K (+2,683.48 %) |
| Jan 03 2020 | OCLS | Sonoma Pharmaceuti ... | Trombly Amy Moss | Chief Executive Off ... | Option Exercise | A | 4.55 | 2,380 | 10,829 | 15,871 | |
| Jan 03 2020 | OCLS | Sonoma Pharmaceuti ... | Trombly Amy Moss | Chief Executive Off ... | Option Exercise | A | 4.36 | 13,491 | 58,821 | 13,491 | |
| Jan 03 2020 | OCLS | Sonoma Pharmaceuti ... | Dal Poggetto John | Chief Financial Off ... | Option Exercise | A | 4.36 | 13,000 | 56,680 | 18,496 | |
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 2.41 | 67,733 | 163,237 | 0 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 7.06 | 30,000 | 211,800 | 67,733 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 4.81 | 50,000 | 240,500 | 97,733 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 30.00 | 20,000 | 600,000 | 147,733 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 32.55 | 4,285 | 139,477 | 167,733 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 43.75 | 5,357 | 234,369 | 172,018 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 56.00 | 1,428 | 79,968 | 177,375 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 70.35 | 3,928 | 276,335 | 178,803 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 68.95 | 1,785 | 123,076 | 182,731 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 66.85 | 3,571 | 238,721 | 184,516 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 38.15 | 5,271 | 201,089 | 188,087 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 2.41 | 67,733 | 163,237 | 0 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 7.06 | 30,000 | 211,800 | 67,733 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 4.81 | 50,000 | 240,500 | 97,733 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 5.80 | 7,912 | 45,890 | 147,733 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 19.50 | 26,020 | 507,390 | 155,645 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 14.85 | 5,351 | 79,462 | 181,665 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 32.55 | 4,285 | 139,477 | 187,016 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 43.75 | 1,785 | 78,094 | 191,301 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 56.00 | 5,000 | 280,000 | 193,086 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 70.35 | 357 | 25,115 | 198,086 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 68.95 | 5,357 | 369,365 | 198,443 | ||
| Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 38.15 | 5,271 | 201,089 | 203,800 | ||
| Jan 11 2019 | OCLS | Sonoma Pharmaceuti ... | Sandford Frederick J | CEO and Interim CFO | Option Exercise | A | 0.72 | 50,000 | 35,850 | 450,000 | |
| Jan 11 2019 | OCLS | Sonoma Pharmaceuti ... | Sandford Frederick J | CEO and Interim CFO | Option Exercise | A | 0.72 | 400,000 | 286,800 | 400,000 | |
| Jul 24 2018 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Option Exercise | A | 2.41 | 67,733 | 163,237 | 193,358 | |
| Jul 24 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 2.41 | 67,733 | 163,237 | 209,071 | |
| Jun 01 2018 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,781 | 0 | 48,728 | 46.9 K to 48.7 K (+3.79 %) |
| Jun 01 2018 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 1,538 | 0 | 46,520 | 45 K to 46.5 K (+3.42 %) |
| Jun 01 2018 | OCLS | Sonoma Pharmaceuti ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 1,052 | 0 | 51,659 | 50.6 K to 51.7 K (+2.08 %) |
| Mar 14 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.10 | 1,200 | 4,920 | 18,868 | 17.7 K to 18.9 K (+6.79 %) |
| Mar 14 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.03 | 1,200 | 4,836 | 17,668 | 16.5 K to 17.7 K (+7.29 %) |
| Mar 13 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.03 | 1,200 | 4,836 | 16,468 | 15.3 K to 16.5 K (+7.86 %) |
| Mar 13 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 3.90 | 1,200 | 4,680 | 15,268 | 14.1 K to 15.3 K (+8.53 %) |
| Mar 08 2018 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 3.99 | 2,473 | 9,867 | 35,858 | 33.4 K to 35.9 K (+7.41 %) |
| Mar 02 2018 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 1,424 | 0 | 43,417 | 42 K to 43.4 K (+3.39 %) |
| Mar 02 2018 | OCLS | Sonoma Pharmaceuti ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 1,157 | 0 | 50,607 | 49.5 K to 50.6 K (+2.34 %) |
| Mar 02 2018 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 1,691 | 0 | 44,982 | 43.3 K to 45 K (+3.91 %) |
| Mar 02 2018 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,958 | 0 | 46,947 | 45 K to 46.9 K (+4.35 %) |
| Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Grant | A | 0.00 | 17,211 | 0 | 33,385 | 16.2 K to 33.4 K (+106.41 %) |
| Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 17,211 | 0 | 44,989 | 27.8 K to 45 K (+61.96 %) |
| Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 17,211 | 0 | 43,291 | 26.1 K to 43.3 K (+65.99 %) |
| Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 25,817 | 0 | 49,450 | 23.6 K to 49.5 K (+109.24 %) |
| Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 17,211 | 0 | 41,993 | 24.8 K to 42 K (+69.45 %) |
| Dec 04 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 4.95 | 345 | 1,708 | 16,174 | 15.8 K to 16.2 K (+2.18 %) |
| Dec 01 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 14,317 | 0 | 27,778 | 13.5 K to 27.8 K (+106.36 %) |
| Dec 01 2017 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 14,130 | 0 | 26,080 | 12 K to 26.1 K (+118.24 %) |
| Dec 01 2017 | OCLS | Sonoma Pharmaceuti ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 13,757 | 0 | 23,633 | 9.9 K to 23.6 K (+139.30 %) |
| Dec 01 2017 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 13,944 | 0 | 24,782 | 10.8 K to 24.8 K (+128.66 %) |
| Nov 30 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.02 | 1,290 | 6,476 | 14,068 | 12.8 K to 14.1 K (+10.10 %) |
| Nov 30 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.03 | 500 | 2,515 | 12,778 | 12.3 K to 12.8 K (+4.07 %) |
| Nov 29 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 5.03 | 400 | 2,012 | 15,829 | 15.4 K to 15.8 K (+2.59 %) |
| Nov 27 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 5.05 | 254 | 1,283 | 15,429 | 15.2 K to 15.4 K (+1.67 %) |
| Nov 24 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.04 | 500 | 2,520 | 12,278 | 11.8 K to 12.3 K (+4.25 %) |
| Nov 24 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.03 | 1,500 | 7,545 | 11,778 | 10.3 K to 11.8 K (+14.59 %) |
| Aug 30 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,210 | 0 | 13,471 | 12.3 K to 13.5 K (+9.87 %) |
| Aug 30 2017 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 1,045 | 0 | 11,950 | 10.9 K to 12 K (+9.58 %) |
| Aug 30 2017 | OCLS | Sonoma Pharmaceuti ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 715 | 0 | 9,876 | 9.2 K to 9.9 K (+7.80 %) |
| Aug 30 2017 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 880 | 0 | 10,838 | 10 K to 10.8 K (+8.84 %) |
| Aug 14 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.30 | 2,264 | 11,999 | 10,728 | 8.5 K to 10.7 K (+26.75 %) |
| Aug 11 2017 | OCLS | Sonoma Pharmaceuti ... | Umscheid Marc | Chief Strategy/Mkt ... | Buy | P | 5.31 | 600 | 3,186 | 3,392 | 2.8 K to 3.4 K (+21.49 %) |
| Aug 10 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 5.46 | 929 | 5,069 | 15,175 | 14.2 K to 15.2 K (+6.52 %) |
| Jun 30 2017 | OCLS | Sonoma Pharmaceuti ... | Umscheid Marc | Chief Strategy/Mkt ... | Grant | A | 0.00 | 2,042 | 0 | 2,792 | 750 to 2.8 K (+272.27 %) |
| Jun 30 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Grant | A | 0.00 | 2,406 | 0 | 14,246 | 11.8 K to 14.2 K (+20.32 %) |
| Jun 30 2017 | OCLS | Sonoma Pharmaceuti ... | Northey Robert Allen | Exe. VP of Research ... | Grant | A | 0.00 | 3,404 | 0 | 8,082 | 4.7 K to 8.1 K (+72.77 %) |
| Jun 30 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Grant | A | 0.00 | 4,124 | 0 | 20,088 | 16 K to 20.1 K (+25.83 %) |
| Jun 01 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,036 | 0 | 12,261 | 11.2 K to 12.3 K (+9.23 %) |
| Jun 01 2017 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 895 | 0 | 10,905 | 10 K to 10.9 K (+8.94 %) |
| Jun 01 2017 | OCLS | Sonoma Pharmaceuti ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 612 | 0 | 9,161 | 8.5 K to 9.2 K (+7.16 %) |
| Jun 01 2017 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 754 | 0 | 9,958 | 9.2 K to 10 K (+8.19 %) |
| Apr 05 2017 | OCLS | Sonoma Pharmaceuti ... | Umscheid Marc | Chief Strategy/Mkt ... | Option Exercise | A | 7.06 | 17,000 | 120,020 | 72,000 | |
| Apr 05 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Option Exercise | A | 7.06 | 30,000 | 211,800 | 133,658 | |
| Apr 05 2017 | OCLS | Sonoma Pharmaceuti ... | Northey Robert Allen | Exec. VP of Res & D ... | Option Exercise | A | 7.06 | 17,000 | 120,020 | 60,310 | |
| Apr 05 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 7.06 | 30,000 | 211,800 | 140,866 | |
| Mar 13 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 7.14 | 250 | 1,785 | 8,464 | 8.2 K to 8.5 K (+3.04 %) |
| Mar 13 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.96 | 250 | 1,740 | 8,214 | 8 K to 8.2 K (+3.14 %) |
| Mar 13 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.97 | 250 | 1,743 | 7,964 | 7.7 K to 8 K (+3.24 %) |
| Mar 09 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.97 | 750 | 5,228 | 7,714 | 7 K to 7.7 K (+10.77 %) |
| Mar 09 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.81 | 250 | 1,703 | 6,964 | 6.7 K to 7 K (+3.72 %) |
| Mar 08 2017 | OCLS | Sonoma Pharmaceuti ... | Umscheid Marc | Chief Strategy/Mkt ... | Buy | P | 6.82 | 750 | 5,115 | 750 | 0 to 750 |
| Mar 07 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 6.75 | 104 | 702 | 11,840 | 11.7 K to 11.8 K (+0.89 %) |
| Mar 07 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 6.78 | 696 | 4,719 | 11,736 | 11 K to 11.7 K (+6.30 %) |
| Mar 02 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 976 | 0 | 11,225 | 10.2 K to 11.2 K (+9.52 %) |
| Mar 02 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 2,250 | 0 | 10,249 | 8 K to 10.2 K (+28.13 %) |
| Mar 02 2017 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 843 | 0 | 10,010 | 9.2 K to 10 K (+9.20 %) |
| Mar 02 2017 | OCLS | Sonoma Pharmaceuti ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 2,250 | 0 | 9,167 | 6.9 K to 9.2 K (+32.53 %) |
| Jan 20 2017 | OCLS | Sonoma Pharmaceuti ... | Umscheid Marc | Chief Strategy/Mkt ... | Option Exercise | A | 5.15 | 55,000 | 283,250 | 55,000 | |
| Dec 12 2016 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.86 | 5,000 | 24,300 | 6,714 | 1.7 K to 6.7 K (+291.72 %) |
| Dec 08 2016 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 4.88 | 1,000 | 4,880 | 11,040 | 10 K to 11 K (+9.96 %) |
| Dec 02 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Option Exercise | A | 4.81 | 50,000 | 240,500 | 103,658 | |
| Dec 02 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Grant | A | 4.81 | 3,535 | 17,003 | 10,040 | 6.5 K to 10 K (+54.34 %) |
| Dec 02 2016 | OCLS | Oculus Innovative ... | Northey Robert Allen | Exec. VP of Res & D ... | Grant | A | 4.81 | 4,678 | 22,501 | 4,678 | 0 to 4.7 K |
| Dec 02 2016 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 4.81 | 50,000 | 240,500 | 110,866 | |
| Dec 02 2016 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Grant | A | 0.00 | 15,593 | 0 | 15,964 | 371 to 16 K (+4,202.96 %) |
| Nov 30 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,423 | 0 | 7,999 | 6.6 K to 8 K (+21.64 %) |
| Nov 30 2016 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 1,229 | 0 | 6,917 | 5.7 K to 6.9 K (+21.61 %) |
| Nov 30 2016 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 841 | 0 | 5,722 | 4.9 K to 5.7 K (+17.23 %) |
| Nov 30 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 1,035 | 0 | 6,244 | 5.2 K to 6.2 K (+19.87 %) |
| Aug 30 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,648 | 0 | 6,576 | 4.9 K to 6.6 K (+33.44 %) |
| Aug 30 2016 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 1,423 | 0 | 5,688 | 4.3 K to 5.7 K (+33.36 %) |
| Aug 30 2016 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 974 | 0 | 4,881 | 3.9 K to 4.9 K (+24.93 %) |
| Aug 30 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 1,199 | 0 | 5,209 | 4 K to 5.2 K (+29.90 %) |
| Aug 16 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Buy | P | 3.66 | 1,328 | 4,866 | 6,505 | 5.2 K to 6.5 K (+25.65 %) |
| Jun 01 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 6,765 | 0 | 24,643 | 17.9 K to 24.6 K (+37.84 %) |
| Jun 01 2016 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 5,090 | 0 | 21,327 | 16.2 K to 21.3 K (+31.35 %) |
| Jun 01 2016 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 4,188 | 0 | 19,541 | 15.4 K to 19.5 K (+27.28 %) |
| Jun 01 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 4,445 | 0 | 20,051 | 15.6 K to 20.1 K (+28.48 %) |
| Mar 02 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 11,250 | 0 | 17,878 | 6.6 K to 17.9 K (+169.73 %) |
| Mar 02 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 6,628 | 0 | 6,628 | 0 to 6.6 K |
| Mar 02 2016 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 11,250 | 0 | 16,237 | 5 K to 16.2 K (+225.59 %) |
| Mar 02 2016 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Grant | A | 0.00 | 4,987 | 0 | 4,987 | 0 to 5 K |
| Mar 02 2016 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 11,250 | 0 | 15,353 | 4.1 K to 15.4 K (+274.19 %) |
| Mar 02 2016 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Grant | A | 0.00 | 4,103 | 0 | 4,103 | 0 to 4.1 K |
| Mar 02 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 11,250 | 0 | 15,606 | 4.4 K to 15.6 K (+258.26 %) |
| Mar 02 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 4,356 | 0 | 4,356 | 0 to 4.4 K |
| Feb 29 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Buy | P | 1.00 | 5,000 | 5,000 | 25,885 | 20.9 K to 25.9 K (+23.94 %) |
| Dec 02 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 1.24 | 7,488 | 9,285 | 146,144 | |
| Dec 02 2015 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Option Exercise | A | 1.24 | 5,633 | 6,985 | 89,487 | |
| Dec 02 2015 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Option Exercise | A | 1.24 | 4,635 | 5,747 | 174,041 | |
| Dec 02 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 1.24 | 4,920 | 6,101 | 80,968 | |
| Sep 02 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 1.21 | 7,774 | 9,407 | 138,656 | |
| Sep 02 2015 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Option Exercise | A | 1.21 | 5,849 | 7,077 | 83,854 | |
| Sep 02 2015 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Option Exercise | A | 1.21 | 4,813 | 5,824 | 169,406 | |
| Sep 02 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 1.21 | 5,109 | 6,182 | 76,048 | |
| Aug 25 2015 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 1.16 | 40,000 | 46,400 | 308,041 | |
| Jun 23 2015 | OCLS | Oculus Innovative ... | Oculus Innovative Sciences, In ... | 10% Owner | Sell | S | 2.75 | 922,500 | 2,536,875 | 0 | 922.5 K to 0 (-100.00 %) |
| Jun 23 2015 | OCLS | Oculus Innovative ... | Oculus Innovative Sciences, In ... | 10% Owner | Sell | S | 2.75 | 727,500 | 2,000,625 | 922,500 | 1.7 M to 922.5 K (-44.09 %) |
| Jun 02 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 0.90 | 10,610 | 9,549 | 130,882 | |
| Jun 02 2015 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Option Exercise | A | 0.90 | 7,983 | 7,185 | 78,005 | |
| Jun 02 2015 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Option Exercise | A | 0.90 | 6,568 | 5,911 | 164,593 | |
| Jun 02 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 0.90 | 6,972 | 6,275 | 70,939 | |
| Mar 24 2015 | OCLS | Oculus Innovative ... | Oculus Innovative Sciences, In ... | 10% Owner | Sell | S | 2.75 | 350,000 | 962,500 | 1,650,000 | 2 M to 1.7 M (-17.50 %) |
| Mar 03 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 0.86 | 11,026 | 9,482 | 120,272 | |
| Mar 03 2015 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Option Exercise | A | 0.86 | 8,296 | 7,135 | 70,022 | |
| Mar 03 2015 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Option Exercise | A | 0.86 | 6,826 | 5,870 | 155,583 | |
| Mar 03 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 0.86 | 7,246 | 6,232 | 63,967 | |
| Dec 02 2014 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 1.40 | 6,773 | 9,482 | 109,246 | |
| Dec 02 2014 | OCLS | Oculus Innovative ... | Harrison Russell Joseph | Director | Option Exercise | A | 1.40 | 5,096 | 7,134 | 61,726 | |
| Dec 02 2014 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Option Exercise | A | 1.40 | 4,193 | 5,870 | 148,757 | |
| Dec 02 2014 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 1.40 | 4,451 | 6,231 | 56,721 | |
| Nov 17 2014 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Buy | P | 1.78 | 6,285 | 11,187 | 20,885 | 14.6 K to 20.9 K (+43.05 %) |
| Oct 01 2014 | OCLS | Oculus Innovative ... | Birnbaum Jay E | Director | Option Exercise | A | 2.21 | 15,000 | 33,150 | 144,564 | |
| Oct 01 2014 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 2.21 | 15,000 | 33,150 | 102,473 |